United Capital Management Of Ks, Inc. Pfizer Inc Transaction History

United Capital Management Of Ks, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 04, 2020	SELL	$27.03 - $38.62 $1.04 Million - $1.49 Million	-38,562 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $138,757 - $157,472	4,215 Added 12.27%	38,562 $1.51 Million
Q3 2019 Oct 15, 2019	BUY	$32.49 - $42.13 $58,904 - $76,381	1,813 Added 5.57%	34,347 $1.23 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $7,913 - $8,885	214 Added 0.66%	32,534 $1.42 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $46,350 - $50,923	1,236 Added 3.98%	32,320 $1.27 Million
Q4 2018 Jan 10, 2019	BUY	$38.47 - $43.86 $28,506 - $32,500	741 Added 2.44%	31,084 $1.36 Million
Q3 2018 Oct 09, 2018	BUY	$34.47 - $41.81 $1.05 Million - $1.27 Million	30,343 New	30,343 $1.31 Million

3,247

3.72B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.